Bone-specific delivery and sustained release of diclofenac, a non-steroidal anti-inflammatory drug, via bisphosphonic prodrug based on the Osteotropic Drug Delivery System (ODDS)

Authors: Hirabayashi H.1; Takahashi T.; Fujisaki J.; Masunaga T.; Sato S.; Hiroi J.; Tokunaga Y.; Kimura S.; Hata T.

Source: Journal of Controlled Release, Volume 70, Number 1, 29 January 2001 , pp. 183-191(9)

Publisher: Elsevier

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: Osteotropic drug delivery system; Biphosphonate; Prodrug; Diclofenac; Rat adjuvant

Language: English

Document Type: Research article

DOI: 10.1016/S0168-3659(00)00355-2

Affiliations: 1: aBiopharmaceutical and Pharmacokinetic Research Laboratories, Fujisawa Pharmaceutical Company, 1-6, Kashima 2-chome, Yodogawa-ku, 532-8514, Osaka, Japan

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A